Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Emerging Roles for CSF-1 Receptor and its Ligands in the Nervous System.

Chitu V, Gokhan Ş, Nandi S, Mehler MF, Stanley ER.

Trends Neurosci. 2016 Jun;39(6):378-93. doi: 10.1016/j.tins.2016.03.005. Epub 2016 Apr 12. Review.

PMID:
27083478
2.

In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders.

Pantazopoulos H, Berretta S.

Neural Plast. 2016;2016:9847696. doi: 10.1155/2016/9847696. Epub 2015 Dec 29. Review.

3.

Proteoglycans and neuronal migration in the cerebral cortex during development and disease.

Maeda N.

Front Neurosci. 2015 Mar 23;9:98. doi: 10.3389/fnins.2015.00098. eCollection 2015. Review.

4.

ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Douet V, Chang L, Lee K, Ernst T; Pediatric Imaging, Neurocognition, and Genetics (PING) Consortium.

Brain Imaging Behav. 2015 Mar;9(1):128-40. doi: 10.1007/s11682-015-9363-y.

5.

S-SCAM, a rare copy number variation gene, induces schizophrenia-related endophenotypes in transgenic mouse model.

Zhang N, Zhong P, Shin SM, Metallo J, Danielson E, Olsen CM, Liu QS, Lee SH.

J Neurosci. 2015 Feb 4;35(5):1892-904. doi: 10.1523/JNEUROSCI.3658-14.2015.

6.

Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala.

Pantazopoulos H, Markota M, Jaquet F, Ghosh D, Wallin A, Santos A, Caterson B, Berretta S.

Transl Psychiatry. 2015 Jan 20;5:e496. doi: 10.1038/tp.2014.128.

7.

Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.

Berretta S, Pantazopoulos H, Markota M, Brown C, Batzianouli ET.

Schizophr Res. 2015 Sep;167(1-3):18-27. doi: 10.1016/j.schres.2014.12.040. Epub 2015 Jan 16. Review.

8.

Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.

Xing J, Wang C, Kimura H, Takasaki Y, Kunimoto S, Yoshimi A, Nakamura Y, Koide T, Banno M, Kushima I, Uno Y, Okada T, Aleksic B, Ikeda M, Iwata N, Ozaki N.

PLoS One. 2014 Nov 13;9(11):e112531. doi: 10.1371/journal.pone.0112531. eCollection 2014.

9.

Perineuronal nets and schizophrenia: the importance of neuronal coatings.

Bitanihirwe BK, Woo TU.

Neurosci Biobehav Rev. 2014 Sep;45:85-99. doi: 10.1016/j.neubiorev.2014.03.018. Epub 2014 Apr 4. Review.

10.

Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities.

Roussos P, Haroutunian V.

Front Cell Neurosci. 2014 Jan 21;8:5. doi: 10.3389/fncel.2014.00005. eCollection 2014. Review.

11.

Proteoglycan abnormalities in olfactory epithelium tissue from subjects diagnosed with schizophrenia.

Pantazopoulos H, Boyer-Boiteau A, Holbrook EH, Jang W, Hahn CG, Arnold SE, Berretta S.

Schizophr Res. 2013 Nov;150(2-3):366-72. doi: 10.1016/j.schres.2013.08.013. Epub 2013 Sep 10.

12.

Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34.

Nandi S, Cioce M, Yeung YG, Nieves E, Tesfa L, Lin H, Hsu AW, Halenbeck R, Cheng HY, Gokhan S, Mehler MF, Stanley ER.

J Biol Chem. 2013 Jul 26;288(30):21972-86. doi: 10.1074/jbc.M112.442731. Epub 2013 Jun 6.

13.
14.

Role of TARP interaction in S-SCAM-mediated regulation of AMPA receptors.

Danielson E, Metallo J, Lee SH.

Channels (Austin). 2012 Sep-Oct;6(5):393-7. doi: 10.4161/chan.21301. Epub 2012 Aug 10.

15.

Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.

Takahashi N, Sakurai T, Bozdagi-Gunal O, Dorr NP, Moy J, Krug L, Gama-Sosa M, Elder GA, Koch RJ, Walker RH, Hof PR, Davis KL, Buxbaum JD.

Transl Psychiatry. 2011 May 10;1:e8. doi: 10.1038/tp.2011.8.

16.

S-SCAM/MAGI-2 is an essential synaptic scaffolding molecule for the GluA2-containing maintenance pool of AMPA receptors.

Danielson E, Zhang N, Metallo J, Kaleka K, Shin SM, Gerges N, Lee SH.

J Neurosci. 2012 May 16;32(20):6967-80. doi: 10.1523/JNEUROSCI.0025-12.2012.

17.

Astrocyte-specific disruption of SynCAM1 signaling results in ADHD-like behavioral manifestations.

Sandau US, Alderman Z, Corfas G, Ojeda SR, Raber J.

PLoS One. 2012;7(4):e36424. doi: 10.1371/journal.pone.0036424. Epub 2012 Apr 30.

18.

Extracellular matrix abnormalities in schizophrenia.

Berretta S.

Neuropharmacology. 2012 Mar;62(3):1584-97. doi: 10.1016/j.neuropharm.2011.08.010. Epub 2011 Aug 16. Review.

19.

Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.

Takahashi N, Nielsen KS, Aleksic B, Petersen S, Ikeda M, Kushima I, Vacaresse N, Ujike H, Iwata N, Dubreuil V, Mirza N, Sakurai T, Ozaki N, Buxbaum JD, Sap J.

Biol Psychiatry. 2011 Oct 1;70(7):626-35. doi: 10.1016/j.biopsych.2011.06.016. Epub 2011 Aug 10.

20.

Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.

Takahashi N, Sakurai T, Davis KL, Buxbaum JD.

Prog Neurobiol. 2011 Jan;93(1):13-24. doi: 10.1016/j.pneurobio.2010.09.004. Epub 2010 Oct 13. Review.

Items per page

Supplemental Content

Write to the Help Desk